Life Whisperer, the fertility arm of AI healthcare company Presagen, has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF. Currently, PGT-A genetic testing requires a portion of a healthy embryo to be removed and sent away for testing. The procedure is invasive, costly, and potentially risky. Presagen CEO, Dr Michelle Perugini said: "Some future parents are just not comfortable with the thought of having to biopsy their embryo, which may ultimately become their baby. PGT-A testing is conducted because evidence suggests genetically healthy embryos can increase pregnancy success and reduce miscarriage for IVF patients who are desperate for children."